Table 3.
Variable | Combined primary fetal and neonatal endpoint |
||||
---|---|---|---|---|---|
n (column %) | Yes (n [row %]) | No (n [row %]) | Crude or only BMI (aOR [95% CI])a | Multivariable (aOR [95% CI])b | |
Model 1 | |||||
GDM | |||||
No GDM or preexisting DM | 126 (9.8) | 189 (16.3) | 970 (83.7) | Ref | Ref |
GDM, no DM | 1159 (90.2) | 28 (2.2) | 98 (77.8) | 1.20 (0.76–1.90) | 1.11 (0.69–1.79) |
BMIc | |||||
Underweight or normal weight (<25 kg/m2) | 690 (53.7) | 87 (12.6) | 603 (87.4) | Ref | Ref |
Overweight or obese (≥25 kg/m2) | 595 (46.3) | 120 (21.9) | 465 (78.2) | 1.89 (1.40–2.56)d | 1.81 (1.32–2.48)d |
Model 2 | |||||
No GDM or DM, underweight or normal weight | 660 (51.4) | 81 (12.3) | 579 (87.7) | Ref | Ref |
No GDM or DM, overweight or obese | 499 (38.8) | 108 (21.6) | 391 (78.4) | 1.97 (1.44–2.71)d | 1.91 (1.37–2.65)d |
GDM, underweight or normal weight | 30 (2.3) | 6 (20.0) | 24 (80.0) | 1.79 (0.71–4.50) | 1.90 (0.75–4.82) |
GDM, overweight or obese | 96 (7.5) | 22 (22.9) | 74 (77.1) | 2.13 (1.25–3.61)d | 1.83 (1.05–3.18)d |
Model 3 | |||||
No GDM or DM, underweight or normal weight | 660 (51.4) | 81 (12.3) | 579 (87.7) | Ref | Ref |
No GDM or DM, overweight or obese | 499 (38.8) | 108 (21.6) | 391 (78.4) | 1.97 (1.44–2.71)d | 1.91 (1.37–2.65)d |
GDM without insulin, underweight or normal weight | 22 (1.7) | 3 (13.6) | 19 (86.4) | 1.13 (0.33–3.90) | 1.17 (0.33–4.09) |
GDM without insulin, overweight or obese | 52 (4.1) | 11 (21.2) | 41 (78.9) | 1.92 (0.95–3.88) | 1.65 (0.79–3.46) |
GDM with insulin, underweight or normal weight | 8 (0.6) | 3 (37.5) | 5 (62.5) | 4.29 (1.01–18.29)d | 4.76 (1.11–20.41)d |
GDM with insulin, overweight or obese | 44 (3.4) | 11 (25.0) | 33 (75.0) | 2.38 (1.16–4.90)d | 2.03 (0.96–4.32) |
Data are presented as aOR (95% CI) using logistic regression analyses with combined primary offspring endpoint (yes or no) as the dependent variable.
aOR, odds ratio; BMI, body mass index; CI, confidence interval; DM, diabetes mellitus; GDM, gestational diabetes mellitus; Ref, reference interval.
Kleinwechter. Gestational diabetes mellitus and COVID-19: COVID-19–Related Obstetric and Neonatal Outcome Study registry results. Am J Obstet Gynecol 2022.
Model 1 adjusted for BMI only and models 2 and 3 unadjusted
Additionally adjusted for week of gestation at the onset of COVID-19 symptoms (or at a positive polymerase chain reaction test result), multiples (yes or no), maternal age at positive COVID-19 test result, language competence (communication possible with or without problems), nicotine or smoking during pregnancy (yes or no), parity (0 or ≥1), and hypertensive disorders in pregnancy (yes or no)
Maternal BMI before or at the beginning of pregnancy (kg/m2)
P<.05.